Tower Research Capital (TRC)’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.6K Buy
2,124
+1,075
+102% +$7.9K ﹤0.01% 3808
2025
Q1
$8.1K Buy
1,049
+197
+23% +$1.52K ﹤0.01% 3917
2024
Q4
$10.3K Sell
852
-6
-0.7% -$73 ﹤0.01% 3814
2024
Q3
$10.8K Buy
858
+609
+245% +$7.64K ﹤0.01% 3721
2024
Q2
$2.97K Sell
249
-2,603
-91% -$31.1K ﹤0.01% 4944
2024
Q1
$49.9K Buy
2,852
+2,186
+328% +$38.2K ﹤0.01% 2275
2023
Q4
$17.1K Buy
666
+398
+149% +$10.2K ﹤0.01% 3749
2023
Q3
$1.94K Buy
268
+182
+212% +$1.32K ﹤0.01% 5237
2023
Q2
$452 Sell
86
-6
-7% -$32 ﹤0.01% 5615
2023
Q1
$0 Sell
92
-94
-51% ﹤0.01% 6004
2022
Q4
$1K Sell
186
-91
-33% -$489 ﹤0.01% 5604
2022
Q3
$1K Buy
277
+119
+75% +$430 ﹤0.01% 5786
2022
Q2
$2K Sell
158
-265
-63% -$3.35K ﹤0.01% 5546
2022
Q1
$2K Buy
+423
New +$2K ﹤0.01% 5554
2021
Q2
Sell
-366
Closed -$14K 5618
2021
Q1
$14K Buy
366
+68
+23% +$2.6K ﹤0.01% 4148
2020
Q4
$14K Sell
298
-2,145
-88% -$101K ﹤0.01% 4092
2020
Q3
$79K Buy
2,443
+933
+62% +$30.2K ﹤0.01% 3316
2020
Q2
$66K Buy
1,510
+1,290
+586% +$56.4K ﹤0.01% 2830
2020
Q1
$8K Sell
220
-138
-39% -$5.02K ﹤0.01% 2119
2019
Q4
$18K Buy
358
+347
+3,155% +$17.4K ﹤0.01% 1990
2019
Q3
$0 Sell
11
-527
-98% ﹤0.01% 4257
2019
Q2
$29K Buy
538
+515
+2,239% +$27.8K ﹤0.01% 1926
2019
Q1
$1K Buy
+23
New +$1K ﹤0.01% 3564
2018
Q4
Sell
-124
Closed -$10K 4025
2018
Q3
$10K Buy
124
+74
+148% +$5.97K ﹤0.01% 2756
2018
Q2
$4K Buy
+50
New +$4K ﹤0.01% 3132
2016
Q3
Sell
-4
Closed -$1K 3948
2016
Q2
$1K Buy
+4
New +$1K ﹤0.01% 4155
2016
Q1
Sell
-5
Closed -$2K 4450
2015
Q4
$2K Sell
5
-13
-72% -$5.2K ﹤0.01% 3736
2015
Q3
$9K Buy
+18
New +$9K ﹤0.01% 2386
2014
Q2
Sell
-3
Closed -$13K 4294
2014
Q1
$13K Buy
+3
New +$13K ﹤0.01% 2341
2013
Q4
Sell
-1
Closed -$5K 4650
2013
Q3
$5K Sell
1
-5
-83% -$25K ﹤0.01% 3651
2013
Q2
$19K Buy
+6
New +$19K ﹤0.01% 1762